Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Talaris Therapeutics, Inc.
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| |
| Debt to EBITDA | | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
| |
| EBITDA interest coverage | | | | 43.7 | | | | 1.2 |
| EBIT interest coverage | | | | 42.4 | | | | 0.0 |
|